Trial · NCT02074358
Adverse events24
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 24
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal Pain | Gastrointestinal disorders | Treatment A: Apixaban + Placebo | 0 | 15 | |
| other | Abdominal Pain | Gastrointestinal disorders | Treatment B: Apixaban + Cofact (4-Factor PCC) | 0 | 15 | |
| other | Abdominal Pain | Gastrointestinal disorders | Treatment C: Apixaban + Beriplex P/N (4-Factor PCC) | 2 | 15 | |
| other | Flatulence | Gastrointestinal disorders | Treatment A: Apixaban + Placebo | 0 | 15 | |
| other | Flatulence | Gastrointestinal disorders | Treatment B: Apixaban + Cofact (4-Factor PCC) | 1 | 15 | |
| other | Flatulence | Gastrointestinal disorders | Treatment C: Apixaban + Beriplex P/N (4-Factor PCC) | 0 | 15 | |
| other | Nasopharyngitis | Infections and infestations | Treatment A: Apixaban + Placebo | 0 | 15 | |
| other | Nasopharyngitis | Infections and infestations | Treatment B: Apixaban + Cofact (4-Factor PCC) | 2 | 15 | |
| other | Nasopharyngitis | Infections and infestations | Treatment C: Apixaban + Beriplex P/N (4-Factor PCC) | 0 | 15 | |
| other | Dizziness | Nervous system disorders | Treatment A: Apixaban + Placebo | 0 | 15 | |
| other | Dizziness | Nervous system disorders | Treatment B: Apixaban + Cofact (4-Factor PCC) | 1 | 15 | |
| other | Dizziness | Nervous system disorders | Treatment C: Apixaban + Beriplex P/N (4-Factor PCC) | 0 | 15 | |
| other | Headache | Nervous system disorders | Treatment A: Apixaban + Placebo | 0 | 15 | |
| other | Headache | Nervous system disorders | Treatment B: Apixaban + Cofact (4-Factor PCC) | 1 | 15 | |
| other | Headache | Nervous system disorders | Treatment C: Apixaban + Beriplex P/N (4-Factor PCC) | 0 | 15 | |
| other | Traumatic Hematoma | Injury, poisoning and procedural complications | Treatment A: Apixaban + Placebo | 1 | 15 | |
| other | Traumatic Hematoma | Injury, poisoning and procedural complications | Treatment B: Apixaban + Cofact (4-Factor PCC) | 0 | 15 | |
| other | Traumatic Hematoma | Injury, poisoning and procedural complications | Treatment C: Apixaban + Beriplex P/N (4-Factor PCC) | 0 | 15 | |
| other | Myalgia | Musculoskeletal and connective tissue disorders | Treatment A: Apixaban + Placebo | 0 | 15 | |
| other | Myalgia | Musculoskeletal and connective tissue disorders | Treatment B: Apixaban + Cofact (4-Factor PCC) | 1 | 15 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02074358/events